J&J paid kickbacks to hike sales of schizophrenia drug: prosecutors
U.S. prosecutors said Friday that health care giant Johnson&Johnson paid tens of millions of dollars in kickbacks so nursing homes would put more patients on its blockbuster schizophrenia medicine and other drugs.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment